These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 6941374)

  • 41. [Effect of pirenzepine on human esophageal motility (author's transl)].
    Denis P; Galmiche JP; Gibon JF; Colin R; Pasquis P; Lefrançois R
    Gastroenterol Clin Biol; 1982 Jan; 6(1):27-31. PubMed ID: 6896038
    [No Abstract]   [Full Text] [Related]  

  • 42. Pharmacology: pirenzepine.
    Hopkins S
    Nurs Mirror; 1983 Jun; 156(24):44. PubMed ID: 6552656
    [No Abstract]   [Full Text] [Related]  

  • 43. [Absorption of dapiprazole in man following single or repeated oral administration].
    Catanese B; Barillari G; Iorio E; Valeri P; Dionisio A
    Boll Chim Farm; 1984 Apr; 123(4):27S-30S. PubMed ID: 6477725
    [No Abstract]   [Full Text] [Related]  

  • 44. A selective radioimmunoassay for the determination of pirenzepine in plasma and urine.
    Homon CA; Esber HJ; Zavorskas P; Tanswell P; Farina PR
    Ther Drug Monit; 1987 Jun; 9(2):236-42. PubMed ID: 3617165
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Metabolic fate of flutoprazepam (KB-509). IV. Pharmacokinetics of flutoprazepam-2-14C and desalkylflutoprazepam-2-14C in dog plasma].
    Kozaki A; Sakurai S; Awata N
    Yakugaku Zasshi; 1982 Dec; 102(12):1177-83. PubMed ID: 7182452
    [No Abstract]   [Full Text] [Related]  

  • 46. A kinetic study of the fate of SL 73033 (antrafenine) in the rat [proceedings].
    Dring LG; Durand A; Gomeni R; Mas-Chamberlain C
    Br J Pharmacol; 1978 Jun; 63(2):368P. PubMed ID: 667447
    [No Abstract]   [Full Text] [Related]  

  • 47. [Urinary excretion and plasma levels of cinepazide in men].
    Oliver MC; Rabiant J
    Ann Pharm Fr; 1977; 35(7-8):265-73. PubMed ID: 603209
    [No Abstract]   [Full Text] [Related]  

  • 48. Effects of ID-540 on averaged photopalpebral reflex in man.
    Tanaka M; Isozaki H; Inanaga K
    Jpn J Pharmacol; 1977 Aug; 27(4):517-22. PubMed ID: 926457
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of duodenal ulcer with pirenzepine and cimetidine.
    Brunner H; Dittrich H; Kratochvil P; Brandstätter G; Hentschel E; Schütze K; Tragl KH; Kern H; Löffelmann K; Zeiler H
    Gut; 1984 Feb; 25(2):206-10. PubMed ID: 6363220
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pirenzepine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in peptic ulcer disease and other allied diseases.
    Carmine AA; Brogden RN
    Drugs; 1985 Aug; 30(2):85-126. PubMed ID: 3928324
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacokinetic and pharmacodynamic studies in man simulating acute and chronic treatment with oral pirenzepine.
    Londong W; Londong V; Federle C; Tanswell P; Voderholzer U
    Eur J Clin Pharmacol; 1989; 36(4):369-74. PubMed ID: 2737229
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Absolute bioavailability of pirenzepine in intensive care patients.
    Tanswell P; Hofgärtner F; Bozler G; Giesler H; Allmendinger G; Schmid E
    Eur J Clin Pharmacol; 1990; 38(3):265-8. PubMed ID: 2340846
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).
    Lauritsen K; Laursen LS; Rask-Madsen J
    Clin Pharmacokinet; 1990 Aug; 19(2):94-125. PubMed ID: 2199130
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An international pharmacokinetic study on pirenzepine following a single oral dose.
    Bozler G; Hammer R
    Scand J Gastroenterol Suppl; 1980; 66():27-33. PubMed ID: 6941374
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Absorption, distribution and excretion of 14C-pirenzepine in rats. Accumulation characteristics after multiple dose regimen.
    Kobayashi S; Kyui S; Yoshida T; Nagakura A; Oiwa Y; Matsumura R; Kohei H
    Arzneimittelforschung; 1981; 31(4):679-90. PubMed ID: 6894697
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasma levels and pharmacokinetics of single and multiple dose of tetrazepam in healthy volunteers.
    Bun H; Philip F; Berger Y; Necciari J; Al-Mallah NR; Serradimign A; Cano JP
    Arzneimittelforschung; 1987 Feb; 37(2):199-202. PubMed ID: 2883980
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.
    Darwish M; Tempero K; Kirby M; Thompson J
    Clin Ther; 2006 May; 28(5):715-24. PubMed ID: 16861093
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetic properties of combination oxycodone plus racemic ibuprofen: two randomized, open-label, crossover studies in healthy adult volunteers.
    Kapil R; Nolting A; Roy P; Fiske W; Benedek I; Abramowitz W
    Clin Ther; 2004 Dec; 26(12):2015-25. PubMed ID: 15823765
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical pharmacokinetics of fluvoxamine: applications to dosage regimen design.
    DeVane CL; Gill HS
    J Clin Psychiatry; 1997; 58 Suppl 5():7-14. PubMed ID: 9184622
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.